Kane Biotech Stock Technical Analysis
| KNBIF Stock | USD 0.03 0 5.52% |
As of the 26th of February, Kane Biotech secures the Mean Deviation of 2.05, downside deviation of 8.51, and Risk Adjusted Performance of 0.0485. Kane Biotech technical analysis lets you operate historical price patterns with an objective to determine a pattern that forecasts the direction of the firm's future prices. Please verify Kane Biotech jensen alpha and the relationship between the value at risk and kurtosis to decide if Kane Biotech is priced some-what accurately, providing market reflects its recent price of 0.0274 per share. As Kane Biotech appears to be a penny stock we also strongly suggest to check its total risk alpha numbers.
Kane Biotech Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Kane, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to KaneKane |
Kane Biotech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Kane Biotech's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Kane Biotech.
| 11/28/2025 |
| 02/26/2026 |
If you would invest 0.00 in Kane Biotech on November 28, 2025 and sell it all today you would earn a total of 0.00 from holding Kane Biotech or generate 0.0% return on investment in Kane Biotech over 90 days. Kane Biotech is related to or competes with Biovaxys Technology. Kane Biotech Inc., a biotechnology company, engages in the research, development, and commercialization of technologies ... More
Kane Biotech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Kane Biotech's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Kane Biotech upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 8.51 | |||
| Information Ratio | 0.0287 | |||
| Maximum Drawdown | 31.6 | |||
| Value At Risk | (5.78) | |||
| Potential Upside | 7.06 |
Kane Biotech Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Kane Biotech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Kane Biotech's standard deviation. In reality, there are many statistical measures that can use Kane Biotech historical prices to predict the future Kane Biotech's volatility.| Risk Adjusted Performance | 0.0485 | |||
| Jensen Alpha | 0.2419 | |||
| Total Risk Alpha | (0.36) | |||
| Sortino Ratio | 0.0157 | |||
| Treynor Ratio | (2.49) |
Kane Biotech February 26, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0485 | |||
| Market Risk Adjusted Performance | (2.48) | |||
| Mean Deviation | 2.05 | |||
| Semi Deviation | 2.94 | |||
| Downside Deviation | 8.51 | |||
| Coefficient Of Variation | 1916.51 | |||
| Standard Deviation | 4.65 | |||
| Variance | 21.62 | |||
| Information Ratio | 0.0287 | |||
| Jensen Alpha | 0.2419 | |||
| Total Risk Alpha | (0.36) | |||
| Sortino Ratio | 0.0157 | |||
| Treynor Ratio | (2.49) | |||
| Maximum Drawdown | 31.6 | |||
| Value At Risk | (5.78) | |||
| Potential Upside | 7.06 | |||
| Downside Variance | 72.42 | |||
| Semi Variance | 8.65 | |||
| Expected Short fall | (8.70) | |||
| Skewness | 1.16 | |||
| Kurtosis | 8.71 |
Kane Biotech Backtested Returns
Kane Biotech appears to be out of control, given 3 months investment horizon. Kane Biotech has Sharpe Ratio of 0.0542, which conveys that the firm had a 0.0542 % return per unit of risk over the last 3 months. We have found twenty-seven technical indicators for Kane Biotech, which you can use to evaluate the volatility of the firm. Please exercise Kane Biotech's Mean Deviation of 2.05, risk adjusted performance of 0.0485, and Downside Deviation of 8.51 to check out if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Kane Biotech holds a performance score of 4. The company secures a Beta (Market Risk) of -0.0934, which conveys not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Kane Biotech are expected to decrease at a much lower rate. During the bear market, Kane Biotech is likely to outperform the market. Please check Kane Biotech's semi variance, day typical price, and the relationship between the value at risk and kurtosis , to make a quick decision on whether Kane Biotech's current price movements will revert.
Auto-correlation | 0.18 |
Very weak predictability
Kane Biotech has very weak predictability. Overlapping area represents the amount of predictability between Kane Biotech time series from 28th of November 2025 to 12th of January 2026 and 12th of January 2026 to 26th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Kane Biotech price movement. The serial correlation of 0.18 indicates that over 18.0% of current Kane Biotech price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.18 | |
| Spearman Rank Test | -0.38 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Kane Biotech technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Kane Biotech Technical Analysis
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Normalized Average True Range is used to analyze tradable apportunities for Kane Biotech across different markets.
About Kane Biotech Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Kane Biotech on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Kane Biotech based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Kane Biotech price pattern first instead of the macroeconomic environment surrounding Kane Biotech. By analyzing Kane Biotech's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Kane Biotech's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Kane Biotech specific price patterns or momentum indicators. Please read more on our technical analysis page.
Kane Biotech February 26, 2026 Technical Indicators
Most technical analysis of Kane help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Kane from various momentum indicators to cycle indicators. When you analyze Kane charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0485 | |||
| Market Risk Adjusted Performance | (2.48) | |||
| Mean Deviation | 2.05 | |||
| Semi Deviation | 2.94 | |||
| Downside Deviation | 8.51 | |||
| Coefficient Of Variation | 1916.51 | |||
| Standard Deviation | 4.65 | |||
| Variance | 21.62 | |||
| Information Ratio | 0.0287 | |||
| Jensen Alpha | 0.2419 | |||
| Total Risk Alpha | (0.36) | |||
| Sortino Ratio | 0.0157 | |||
| Treynor Ratio | (2.49) | |||
| Maximum Drawdown | 31.6 | |||
| Value At Risk | (5.78) | |||
| Potential Upside | 7.06 | |||
| Downside Variance | 72.42 | |||
| Semi Variance | 8.65 | |||
| Expected Short fall | (8.70) | |||
| Skewness | 1.16 | |||
| Kurtosis | 8.71 |
Kane Biotech February 26, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Kane stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.00 | ||
| Daily Balance Of Power | (Huge) | ||
| Rate Of Daily Change | 0.94 | ||
| Day Median Price | 0.03 | ||
| Day Typical Price | 0.03 | ||
| Price Action Indicator | 0.00 |
Complementary Tools for Kane Pink Sheet analysis
When running Kane Biotech's price analysis, check to measure Kane Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kane Biotech is operating at the current time. Most of Kane Biotech's value examination focuses on studying past and present price action to predict the probability of Kane Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kane Biotech's price. Additionally, you may evaluate how the addition of Kane Biotech to your portfolios can decrease your overall portfolio volatility.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |